There were 1,667 press releases posted in the last 24 hours and 413,931 in the last 365 days.

Signal Management Processes Following EMA Guidelines

Pharmacovigilance, Drug Safety and Risk Management 2015 - A CPD Certified Conference

I have been part of implementing a new signal management process in Novo Nordisk according to EMA regulations and guidelines
— Dr Kashif Sheikh
LONDON, LONDON, UNITED KINGDOM, April 16, 2015 /EINPresswire.com/ -- SMi Group are delighted to have Novo Nordisk present at its 4th annual Pharmacovigilance, Drug Safety and Risk Management conference this May when it returns to London on 11th and 12th May 2015.

“I have been part of implementing a new signal management process in Novo Nordisk according to EMA regulations and guidelines. The perspective I will bring is practical experience working with the new regulations. Hopefully I should be able to provide attendees with an overview of how patient safety is thought into the drug development cycle as well as the post-marketing phase at Novo Nordisk. I will also present some of the challenges we face" - Dr Kashif Sheikh, Senior Safety Surveillance Advisor, Novo Nordisk

Click here for presentation details

Signal detection analysis will be a major focus of the CPD certified conference and will also include addresses from Quintiles, Mundipharma and Drug Research Safety Unit.

Plus, following on from a recent PRAC meeting, delegates will also hear a keynote from PRAC member, Doris Irene Stenver, who will be providing the latest PRAC updates in an address on greater integration and internationalisation.

A snap shot of those who have already confirmed attendance include:

Bluefish pharmaceuticals, Daiichi Sankyo UK Ltd, Danish Medicines Agency, Drug Safety Research Unit, EudraVigilance Consultants, MedDRA Maintenance and Support Services Organisation (MSSO), NDA Regulatory Science, Novartis International AG, Novonordisk, Pfizer Ltd, pharsafer associates, ProductLife, Quintiles, Roche Products, Royal College of Physicians London, Solvay Pharmaceuticals, Takeda Chemical Industries, TEVA Pharmaceuticals, Vifor Pharma.

For further information or to register, please visit www.pharmacovigilance-event.co.uk

Pharmacovigilance, Drug Safety & Risk Management
11-12 May 2015
Holiday Inn Regents Park Hotel, London UK
www.pharmacovigilance-event.co.uk

---END---

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Teri Arri
SMi Group Ltd
+44 (0)20 7827 6162
email us here